KIMBERLY MUCHORI: Open Payments
NPI 1528724804 · NORTH LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152 in 8 payments from 6 companies in 2025. Trend: 2023 $215 · 2024 $203 · 2025 $152
Food & beverage: $152
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation | 2 | $42 |
| Amgen Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: AFREZZA, UBRELVY, Repatha, MOUNJARO, Dexcom G6 Transmitter, OTEZLA, XIFAXAN.
Industry payments across NV — which companies pay providers there.
